title: A cost analysis of coronary stenting without anticoagulation versus stenting with anticoagulation using warfarin.
abstract: A case-controlled study was performed comparing hospitalization costs and length of hospital stay in a group of patients managed with antiplatelet therapy only, versus a group treated with anticoagulation using warfarin after coronary artery stenting. The patients managed with antiplatelet therapy alone had significantly reduced total hospitalization costs and a significantly reduced average hospital stay than patients managed with anticoagulation.
authors: Division of Cardiovascular Diseases, University of Alabama of Birmingham 35294, USA.
authors: C M
authors: CM
authors: Goods
authors: M W
authors: MW
authors: Liu
authors: S S
authors: SS
authors: Iyer
authors: J S
authors: JS
authors: Yadav
authors: K F
authors: KF
authors: al-Shaibi
authors: L S
authors: LS
authors: Dean
authors: G S
authors: GS
authors: Roubin
mesh_terms: D000368:Aged; D000407:Alabama; D015906:Angioplasty, Balloon, Coronary / Q000191:economics*; D016022:Case-Control Studies; D003365:Costs and Cost Analysis; D005260:Female; D017721:Hospital Costs / Q000706:statistics & numerical data*; D006801:Humans; D007902:Length of Stay / Q000191:economics; D008297:Male; D008875:Middle Aged; D015607:Stents / Q000191:economics*; D014859:Warfarin / Q000191:economics* / Q000627:therapeutic use
chemical_list: D014859:Warfarin